Cell Rep Med August 2024 PMID 39168095

Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial.

Anne-Laure Agrinier, Arianne Morissette, Laurence Daoust, Théo Gignac, Julie Marois, Thibault V Varin, Geneviève Pilon, Éric Larose, Claudia Gagnon, Yves Desjardins, Fernando F Anhê, Anne-Marie Carreau, Marie-Claude Vohl, André Marette

Mentions

73
Peak: 15 in Sep 2024
across 4 sources since Aug 2024

Extended reach

338,832
potential audience

Total likes

43

Video views

537

Mentions per month

Aug 2024 – Sep 2024

Where it's discussed

  • News51 articles
  • X / Twitter16 posts
  • Blogs4 articles
  • YouTube2 videos

AI synopsis

What people are saying

Discussions show enthusiasm with phrases like 'promising benefits' and mention of natural antioxidants, signaling strong interest. The tone varies from supportive acknowledgment to curiosity about implications, with some posts referencing the specific study design to indicate engagement. Overall, the conversations suggest a recognition of the research's possible influence on health practices without extraordinary claims of revolutionizing treatment.

AgreementModerate agreement

Most discussions recognize the positive findings of the study, noting camu-camu's potential benefits for liver health.

InterestHigh interest

Posts show a high level of curiosity, highlighting the natural fruit's antioxidants and its promising health implications.

EngagementModerate engagement

Several discussions include detailed mentions of the study's methodology and potential uses, indicating moderate to deep engagement.

ImpactModerate impact

Some posts suggest the research could influence dietary approaches or treatments for liver issues, reflecting a recognition of its potential impact.

Abstract in brief

  • Non-alcoholic fatty liver disease (NAFLD) affects 25% of adults, and there are currently no effective drug treatments for it.
  • Previous studies indicated that a polyphenol-rich extract from camu-camu berries might prevent fat accumulation in the liver in mice.
  • A 12-week trial with 30 overweight adults found that camu-camu significantly reduced liver fat and positively altered gut microbiota compared to a placebo, suggesting its potential as a dietary intervention for reducing NAFLD risk.

Top posts

Most liked on X and Bluesky
J P Fanton
@HealthyFellow · X

Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized crossover trial ⁦@_atanas_⁩ ⁦@_INPST⁩ ⁦@ScienceCommuni2⁩ ⁦@DHPSP⁩ ⁦@Grimhood⁩ ⁦@DrRPalmquist⁩ @erlesen https://t.co/z7SoNIPXwS

Sep 3, 2024 · 17 likes · 8 shares · 26,025 followers View post →
Outbreak Updates
@outbreakupdates · X

Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals https://t.co/yx6Dd8FzHy

Aug 25, 2024 · 10 likes · 100,799 followers View post →
Dr Thomas NΞNNINGΞR
@T_Nenninger · X

Prometteur pour les NASH Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial: Cell Reports Medicine https://t.co/Jvyl60WU2E

Aug 29, 2024 · 1 like · 32,098 followers View post →
Mg2+ Papi, the BowTied Mg2+
@Grimhood · X

RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…

Sep 3, 2024 · 8 shares · 134,067 followers View post →
Cell Reports Medicine
@CellRepMed · X

Online now: Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial https://t.co/HCMY5ruugR

Sep 4, 2024 · 18,934 followers View post →
Reiner 
@erlesen · X

RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…

Sep 5, 2024 · 8 shares · 7,859 followers View post →

All mentions

bioenergeticbot
@bioenergeticbot · X

Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial https://t.co/IdFEdgxQFK Not Medical Advice || DavidPS

Sep 15, 2024 · 327 followers View post →
Ralph Turchiano
@RalphTurchiano · X

The Liver-Healthy Benefits of Camu-Camu Ep. 1206 SEP 2024 https://t.co/ltJvag8rPV via @YouTube The Liver-Healthy Benefits of Camu-Camu Ep. 1206 SEP 2024 Recent research suggests that camu-camu, a vibrant Amazonian fruit packed with antioxidants, may offer significant benefits

Sep 15, 2024 · 128 followers View post →
Ralph Turchiano
@RalphTurchiano · X

The Liver-Healthy Benefits of Camu-Camu Ep. 1206 SEP 2024 #trailer https://t.co/cIRbnbMq23 via @YouTube Recent research suggests that camu-camu, a vibrant Amazonian fruit packed with antioxidants, may offer significant benefits for liver health. Studies have shown that camu-camu

Sep 7, 2024 · 128 followers View post →
Reiner 
@erlesen · X

RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…

Sep 5, 2024 · 8 shares · 7,859 followers View post →
Divinity Seven♻️
@SevenDivinity · X

RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…

Sep 4, 2024 · 8 shares · 1,398 followers View post →
Cell Reports Medicine
@CellRepMed · X

Online now: Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial https://t.co/HCMY5ruugR

Sep 4, 2024 · 18,934 followers View post →
AngryPhDstudent❗️❗️❗️
@ONNESHA092 · X

RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…

Sep 4, 2024 · 8 shares · 181 followers View post →
Science Communication
@ScienceCommuni2 · X

RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…

Sep 3, 2024 · 8 shares · 2,873 followers View post →
Frank Paul Mora
@InTime_49 · X

RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…

Sep 3, 2024 · 8 shares · 391 followers View post →
Dr Richard Palmquist
@DrRPalmquist · X

RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…

Sep 3, 2024 · 8 shares · 4,722 followers View post →
Mg2+ Papi, the BowTied Mg2+
@Grimhood · X

RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…

Sep 3, 2024 · 8 shares · 134,067 followers View post →
Alper Aydın (Dietitian )
@aydinnalper · X

RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…

Sep 3, 2024 · 8 shares · 1,422 followers View post →
J P Fanton
@HealthyFellow · X

Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized crossover trial ⁦@_atanas_⁩ ⁦@_INPST⁩ ⁦@ScienceCommuni2⁩ ⁦@DHPSP⁩ ⁦@Grimhood⁩ ⁦@DrRPalmquist⁩ @erlesen https://t.co/z7SoNIPXwS

Sep 3, 2024 · 17 likes · 8 shares · 26,025 followers View post →
Johnny
@JohnnyNoblebody · X

Camu-Camu, a small tart red berry found to reduce Non-alcoholic fatty liver disease (NAFLD). https://t.co/JkJdaE2Jye

Aug 29, 2024 · 6,800 followers View post →
Dr Thomas NΞNNINGΞR
@T_Nenninger · X

Prometteur pour les NASH Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial: Cell Reports Medicine https://t.co/Jvyl60WU2E

Aug 29, 2024 · 1 like · 32,098 followers View post →
Outbreak Updates
@outbreakupdates · X

Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals https://t.co/yx6Dd8FzHy

Aug 25, 2024 · 10 likes · 100,799 followers View post →